The Arteriovenous Vascular (AV) ACCESS Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

August 31, 2027

Conditions
End-Stage Kidney DiseaseHemodialysis Complication
Interventions
DEVICE

AV graft

The purpose of the surgery is to connect a large vein in the arm to a nearby artery indirectly by inserting a graft material (graft surgery)

PROCEDURE

surgical intervention for creation of a fistula

The purpose of the surgery is to connect a large vein in the arm to a nearby artery directly (fistula surgery)

Trial Locations (7)

21205

Johns Hopkins School of Medicine, Baltimore

27157

Atrium Wake Forest Baptist Medical Center, Winston-Salem

29601

Prisma Health Upstate, Greenville

35487

University of Alabama at Birmingham School of Medicine, Birmingham

37920

University of Tennessee Medical Center at Knoxville, Knoxville

53726

University of Wisconsin School of Medicine and Public Health, Madison

90095

UCLA, Los Angeles

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Wake Forest University Health Sciences

OTHER